Skip to content

Kidney cancer treatment & outcome study.

KIDNEY CANCER REGISTRY

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2012/11/003147
Enrollment
100
Registered
2012-11-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- kidney cancer patients taking treatment at tata memorial hospital

Interventions

None listed

Sponsors

Indian Cooperative Oncology Network
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: It ia an observational study to study the incidence treatment & outcome of kidney cancer patients taking treatment at our hospital as per the standard guidelines.. No intervention or comparator agent is studied. Registry in CTRI is done as per the requirement of the IRB for this observational study.

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
To study the disease free & overall survival of Kidney cancer patients treated with surgery / chemotherapy / biological therapy/ radiotherapy as per the stat dared guidelines.Timepoint: 2 Years.

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactDr Amit Joshi

Tata Memorial hospital

dramit74@yahoo.com9769331525

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026